The EU's medicine watchdog recently declined to approve lecanemab and is still reviewing donanemab. These Alzheimer's treatments, approved in the US last year and developed by Biogen and Eli Lilly, ...
Annovis is at the forefront, testing buntanetap in pivotal clinical trials as a therapy for Alzheimer's and Parkinson's diseases (PD). Company has filed three new patents protecting combinations of ...
Alzheimer's disease (AD) has become a focal point in the pharmaceutical industry as recent drugs such as Leqembi and Kisunla have received ...